Trials / Completed
CompletedNCT07341607
STRUCTURED PATIENT EDUCATION IN ESWL PATIENTS
Effect of Structured Patient Education on Anxiety Levels and Quality of Life in Patients Undergoing Extracorporeal Shock Wave Lithotripsy: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 188 (actual)
- Sponsor
- KTO Karatay University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Urolithiasis is a common urological disease with an increasing prevalence and high recurrence rates, negatively affecting patients' quality of life. Extracorporeal shock wave lithotripsy is a frequently preferred non-invasive treatment option in appropriate cases; however, uncertainties related to the procedural process and inadequate patient information may lead to increased anxiety and a decline in quality of life. Structured patient education delivered under nurse leadership has emerged as a potential approach to mitigate these adverse effects. Nevertheless, studies evaluating the impact of structured patient education on anxiety levels and quality of life in patients undergoing extracorporeal shock wave lithotripsy remain limited.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Intervention Group | Intervention Group Patients in the intervention group will receive a nurse-led structured patient education program covering both the pre- and post-extracorporeal shock wave lithotripsy (ESWL) periods. The education program has been developed in accordance with the current urolithiasis guidelines published by the European Association of Urology (Skolarikos et al., 2025) and the American Urological Association (Akram et al., 2024), as well as relevant up-to-date scientific literature (Geraghty et al., 2023; Jiang et al., 2021; Kasab et al., 2023; Koudonas et al., 2025; Tzelves et al., 2021). |
Timeline
- Start date
- 2025-09-25
- Primary completion
- 2026-01-01
- Completion
- 2026-01-06
- First posted
- 2026-01-14
- Last updated
- 2026-01-14
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07341607. Inclusion in this directory is not an endorsement.